Position in GERN
as of Jun 30, 2026
· filed Aug 4, 2026
Position Value
$54,776
-$4,107 QoQ
Shares Held
42,794
+8.3% QoQ
Ownership
0.007%
of shares outstanding
% of Portfolio
0.00%
of 13F equity value
Holder Rank
#154
of 258 holders
Holding Since
Mar 2020
25 quarters on record
Voting authority
Sole 100%
Shared 0%
None 0%
Common Shares in GERN Over Time
Shares Held
Position Value (USD)
Position in Biotechnology
Healthcare · as of Jun 30, 2026PRINCIPAL FINANCIAL GROUP INC holds $1,852,088,599 across 105 Biotechnology names. GERN ranks #97 (0.0% of the industry book) .
| # | Ticker | Company | Shares | Value (USD) | Open |
|---|---|---|---|---|---|
| 1 | ASND |
Ascendis Pharma A/S
|
873,502 | $232,980,453 | |
| 2 | VRTX |
Vertex Pharmaceuticals Inc / Ma
|
389,511 | $193,481,798 | |
| 3 | CYTK |
Cytokinetics Inc
|
1,311,664 | $111,740,655 | |
| 4 | GPCR |
Structure Therapeutics Inc.
|
1,752,753 | $94,070,253 | |
| 5 | INSM |
INSMED Inc
|
856,126 | $91,280,154 | |
| 6 | AXSM |
Axsome Therapeutics, Inc.
|
332,642 | $81,420,782 | |
| 7 | BBIO |
BridgeBio Pharma, Inc.
|
1,024,423 | $76,299,024 | |
| 8 | REGN |
Regeneron Pharmaceuticals, Inc.
|
121,053 | $75,481,386 |
All Filings in GERN
Export CSV
25 filing rows on record
| Report Date | Value (USD) | Shares | Type | Discretion | Filed | |
|---|---|---|---|---|---|---|
| 2026-06-30 | $54,776 | 42,794 | Shares | Defined | 2026-08-04 | |
| 2026-03-31 | $58,883 | 39,519 | Shares | Defined | 2026-05-04 | |
| 2025-12-31 | $43,303 | 32,806 | Shares | Defined | 2026-02-02 | |
| 2025-09-30 | $57,253 | 41,791 | Shares | Defined | 2025-11-04 | |
| 2025-06-30 | $60,880 | 43,178 | Shares | Defined | 2025-08-08 | |
| 2025-03-31 | $71,322 | 44,857 | Shares | Defined | 2025-04-28 | |
| 2024-12-31 | $157,760 | 44,565 | Shares | Defined | 2025-01-31 | |
| 2024-09-30 | $225,919 | 49,762 | Shares | Defined | 2024-10-31 | |
| 2024-06-30 | $386,407 | 91,134 | Shares | Defined | 2024-07-29 | |
| 2024-03-31 | $429,821 | 130,249 | Shares | Defined | 2024-04-29 | |
| 2023-12-31 | $273,537 | 129,639 | Shares | Defined | 2024-02-07 | |
| 2023-09-30 | $273,701 | 129,105 | Shares | Defined | 2023-11-02 | |
| 2023-06-30 | $408,542 | 127,272 | Shares | Defined | 2023-08-07 | |
| 2023-03-31 | $225,889 | 104,097 | Shares | Defined | 2023-05-09 | |
| 2022-12-31 | $235,821 | 97,447 | Shares | Defined | 2023-02-09 | |
| 2022-09-30 | $111,433 | 47,621 | Shares | Defined | 2022-11-09 | |
| 2022-06-30 | $69,677 | 44,953 | Shares | Defined | 2022-08-10 | |
| 2022-03-31 | $32,678 | 24,028 | Shares | Defined | 2022-05-09 | |
| 2021-12-31 | $32,171 | 26,370 | Shares | Defined | 2022-02-09 | |
| 2021-09-30 | $34,828 | 25,422 | Shares | Defined | 2021-11-09 | |
| 2021-06-30 | $49,065 | 34,798 | Shares | Defined | 2021-08-10 | |
| 2021-03-31 | $44,767 | 28,334 | Shares | Defined | 2021-05-10 | |
| 2020-09-30 | $37,065 | 21,302 | Shares | Defined | 2020-11-06 | |
| 2020-06-30 | $46,100 | 21,147 | Shares | Defined | 2020-08-05 | |
| 2020-03-31 | $24,894 | 20,920 | Shares | Defined | 2020-05-12 | |
| No filing history on record for this holder in this stock. | ||||||